Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Faget

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncotarget|September 8, 2018
Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cellsSvenja Groeneveld, Julien Faget, Nadine Zangger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2017
RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung AdenocarcinomaJulien Faget, Caroline Contat, Nadine Zangger, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
Frontiers in Immunology|May 14, 2023
Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractorinessChiara Ursino, Cécile Mouric, Laurent Gros, et al.
Frontiers in Immunology|June 3, 2021
Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING PathwayJulie Constanzo, Julien Faget, Chiara Ursino, et al.
Targeted Oncology|February 14, 2012
Targeting regulatory T cellsChristine Ménétrier-Caux, Tyler Curiel, Julien Faget, et al.
Oncoimmunology|August 31, 2012
Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environmentChristine Ménétrier-Caux, Julien Faget, Cathy Biota, et al.
Oncoimmunology|June 27, 2013
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4<sup>+</sup> T cells by plasmacytoid dendritic cellsJulien Faget, Vanja Sisirak, Jean-Yves Blay, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanomaKatarina Pinjusic, Olivier Andreas Dubey, Olga Egorova, et al.
Seminars in Immunopathology|January 4, 2023
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncologyYaël Glasson, Laure-Agnès Chépeaux, Anne-Sophie Dumé, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncotarget|September 8, 2018
Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cellsSvenja Groeneveld, Julien Faget, Nadine Zangger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2017
RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung AdenocarcinomaJulien Faget, Caroline Contat, Nadine Zangger, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
Frontiers in Immunology|May 14, 2023
Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractorinessChiara Ursino, Cécile Mouric, Laurent Gros, et al.
Frontiers in Immunology|June 3, 2021
Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING PathwayJulie Constanzo, Julien Faget, Chiara Ursino, et al.
Targeted Oncology|February 14, 2012
Targeting regulatory T cellsChristine Ménétrier-Caux, Tyler Curiel, Julien Faget, et al.
Oncoimmunology|August 31, 2012
Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environmentChristine Ménétrier-Caux, Julien Faget, Cathy Biota, et al.
Oncoimmunology|June 27, 2013
ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4<sup>+</sup> T cells by plasmacytoid dendritic cellsJulien Faget, Vanja Sisirak, Jean-Yves Blay, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanomaKatarina Pinjusic, Olivier Andreas Dubey, Olga Egorova, et al.
Seminars in Immunopathology|January 4, 2023
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncologyYaël Glasson, Laure-Agnès Chépeaux, Anne-Sophie Dumé, et al.
Pageof 3